Jim Chilcott, David H Miller, Chris McCabe, Paul Tappenden, Anthony O'Hagan, Nicola J Cooper et al
Chilcott J, Miller D H, McCabe C, Tappenden P, O'Hagan A, Cooper N J et al.
Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosisCommentary: Evaluating disease modifying treatments in multiple sclerosis
BMJ 2003; 326 :522
doi:10.1136/bmj.326.7388.522